Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial (Q30758991)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial |
scientific article |
Statements
1 reference
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial (English)
1 reference
Giuseppe Viale
1 reference
Amylou C Dueck
1 reference
Aron Goldhirsch
1 reference
Edith A Perez
1 reference
Istvan Lang
1 reference
Eileen Holmes
1 reference
José Baselga
1 reference
Jo Anne Zujewski
1 reference
Alison Armour
1 reference
Kathleen I Pritchard
1 reference
Ann E McCullough
1 reference
Stella Dolci
1 reference
Eleanor McFadden
1 reference
Andrew P Holmes
1 reference
Liu Tonghua
1 reference
Phuong Dinh
1 reference
Sergei Tjulandin
1 reference
Young-Hyuck Im
1 reference
Véronique Diéras
1 reference
David W Hillman
1 reference
Christian Jackisch
1 reference
Ian Smith
1 reference
Frances Boyle
1 reference
Binghe Xu
1 reference
Thomas Suter
1 reference
Richard D Gelber
1 reference
23 November 2015
1 reference
1 reference
1034-1042
1 reference
Identifiers
1 reference
1 reference
1 reference